What is Boston Scientific's D&A?

Boston Scientific (BSX) reported D&A of $351M in Q1 2026.

How has Boston Scientific's D&A changed year-over-year?

Boston Scientific's D&A increased by 8.0% year-over-year, from $325M to $351M.

What is the long-term trend for Boston Scientific's D&A?

Over 4 years (2021 to 2025), Boston Scientific's D&A has grown at a 5.8% compound annual growth rate (CAGR), from $1.09B to $1.37B.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Boston Scientific BSX D&A

D&A at other companies

TFX

TeleflexTFX

$19.85M+52.3%

Johnson & JohnsonJNJ

$2B+13.1%

HaemoneticsHAE

$27.32M-3.2%

CONMEDCNMD

$4.17M-1.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

Edwards LifesciencesEW

$40.9M+11.7%

Segments

By segment

See full

Cardiovascular$89M+14.1%

MedSurg$29M+7.4%

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$63.44B-56.6%

P/E17.8×-40.8×

P/S3.1×-4.8×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's D&A?: Boston Scientific (BSX) reported D&A of $351M in Q1 2026.
How has Boston Scientific's D&A changed year-over-year?: Boston Scientific's D&A increased by 8.0% year-over-year, from $325M to $351M.
What is the long-term trend for Boston Scientific's D&A?: Over 4 years (2021 to 2025), Boston Scientific's D&A has grown at a 5.8% compound annual growth rate (CAGR), from $1.09B to $1.37B.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.